CERS2 and cardiac hypertrophy: Recently, we reported that with CERS2 KD alone, we observed changes in many pathways crucial for worsening cardiac hypertrophy, suggesting CERS2 KD and the corresponding reduction of cellular levels of VLC sphingolipids, by itself, influence a HF phenotype within these cells [15].